$MPW
MEDICAL PROPERTIES TRUST INC Stock $mpw

$mpw Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000095017022009064 Filed on May 10, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q4
Revenue	$400.2M	$409.8M	$409.3M
YoY Change	4.83%	12.97%	22.63%
Cost Of Revenue	$21.14M	$93.99M	$7.833M
YoY Change	13.12%	123.58%	37.42%
Gross Profit	$379.1M	$315.8M	$401.5M
YoY Change	4.4%	-1.53%	22.37%
Gross Profit Margin	94.72%	77.06%	98.09%
Selling, General & Admin	$38.86M	$41.42M	$38.33M
YoY Change	12.49%	14.75%	11.09%
% of Gross Profit	10.25%	13.12%	9.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$87.32M	$88.76M	$87.66M
YoY Change	10.42%	12.92%	16.57%
% of Gross Profit	23.03%	28.11%	21.83%
Operating Expenses	$123.2M	$126.7M	$122.5M
YoY Change	11.07%	13.46%	14.72%
Operating Profit	$255.9M	$189.1M	$279.0M
YoY Change	1.47%	-9.55%	26.06%
Interest Expense	-$73.56M	$91.18M	-$112.4M
YoY Change	-13.49%	4.84%	4.5%
% of Operating Profit	-28.75%	48.23%	-40.3%
Other Income/Expense, Net	$2.031M	$460.0M	$1.541M
YoY Change	-363.42%	3278.97%	-42.93%
Pretax Income	$200.7M	$643.3M	$211.7M
YoY Change	21.65%	273.51%	81.99%
Income Tax	$10.66M	$11.38M	$4.807M
% Of Pretax Income	5.31%	1.77%	2.27%
Net Earnings	$189.6M	$631.7M	$206.5M
YoY Change	65.12%	285.68%	87.93%
Net Earnings / Revenue	47.37%	154.14%	50.46%
Basic Earnings Per Share	$0.32	$1.05
Diluted Earnings Per Share	$316.5K	$1.055M	$346.2K
COMMON SHARES
Basic Shares Outstanding	600.1M	598.7M
Diluted Shares Outstanding	599.0M	598.9M

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$257.3M	$248.8M	$459.2M
YoY Change	-64.33%	-66.69%	-16.5%
Cash & Equivalents	$257.3M	$248.8M	$459.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$960.0M	$909.3M	$1.188B
YoY Change	-27.46%	-29.62%	14.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.88B	$18.25B	$16.43B
YoY Change	21.9%	25.45%	21.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$1.200B
YoY Change			9.09%
Other Assets
YoY Change
Total Long-Term Assets	$18.78B	$18.91B	$19.33B
YoY Change	5.74%	8.33%	22.44%
TOTAL ASSETS
Total Short-Term Assets	$960.0M	$909.3M	$1.188B
Total Long-Term Assets	$18.78B	$18.91B	$19.33B
Total Assets	$19.74B	$19.82B	$20.52B
YoY Change	3.44%	5.72%	21.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$562.3M	$595.0M	$607.8M
YoY Change	-13.86%	33.41%	38.45%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$717.2M	$761.7M	$765.8M
YoY Change	-10.43%	25.89%	31.58%
LONG-TERM LIABILITIES
Long-Term Debt	$10.14B	$10.12B	$11.28B
YoY Change	0.91%	1.18%	27.24%
Other Long-Term Liabilities	$21.21M	$18.83M	$25.56M
YoY Change	0.11%	-14.39%	-28.99%
Total Long-Term Liabilities	$10.16B	$10.14B	$11.31B
YoY Change	0.91%	1.15%	27.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$717.2M	$761.7M	$765.8M
Total Long-Term Liabilities	$10.16B	$10.14B	$11.31B
Total Liabilities	$10.88B	$10.90B	$12.07B
YoY Change	0.08%	2.52%	27.29%
SHAREHOLDERS EQUITY
Retained Earnings	$385.5M	$370.0M	-$87.69M
YoY Change			22.8%
Common Stock	$8.558B	$8.548B	$8.565B
YoY Change			14.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$777.0K
YoY Change			0.0%
Treasury Stock Shares
Shareholders Equity	$8.860B	$8.913B	$8.440B
YoY Change
Total Liabilities & Shareholders Equity	$19.74B	$19.82B	$20.52B
YoY Change	3.44%	5.72%	21.93%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q4
OPERATING ACTIVITIES
Net Income	$189.6M	$631.7M	$206.5M
YoY Change	65.12%	285.68%	87.93%
Depreciation, Depletion And Amortization	$87.32M	$88.76M	$87.66M
YoY Change	10.42%	12.92%	16.57%
Cash From Operating Activities	$164.6M	$179.4M	$234.2M
YoY Change	-6.76%	-4.95%	33.51%
INVESTING ACTIVITIES
Capital Expenditures	-$276.5M	-$760.9M	-$1.139B
YoY Change	-78.46%	-57.21%	51.76%
Acquisitions
YoY Change
Other Investing Activities	-$68.41M	$1.640B	$500.3M
YoY Change	-106.21%	-53001.42%	-9.15%
Cash From Investing Activities	-$344.9M	$879.0M	-$638.5M
YoY Change	90.32%	-149.34%	219.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$869.6M
YoY Change		26.13%
Cash From Financing Activities	201.1M	-1.264B	511.0M
YoY Change	-864.79%	-170.79%	33.31%
NET CHANGE
Cash From Operating Activities	164.6M	179.4M	234.2M
Cash From Investing Activities	-344.9M	879.0M	-638.5M
Cash From Financing Activities	201.1M	-1.264B	511.0M
Net Change In Cash	20.82M	-205.4M	106.7M
YoY Change	-167.24%	-206.78%	-70.28%
FREE CASH FLOW
Cash From Operating Activities	$164.6M	$179.4M	$234.2M
Capital Expenditures	-$276.5M	-$760.9M	-$1.139B
Free Cash Flow	$441.1M	$940.3M	$1.373B
YoY Change	-69.79%	-52.2%	48.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001287865
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-32559
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	MEDICAL PROPERTIES TRUST, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-0191742
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1000 URBAN CENTER DRIVE
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	SUITE 501
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	BIRMINGHAM
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	AL
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	35242
CY2022Q1	dei	City Area Code CityAreaCode	205
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	969-3755
CY2022Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share, of Medical Properties Trust, Inc.
CY2022Q1	dei	Trading Symbol TradingSymbol	MPW
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	600100000
CY2022Q1	mpw	Land Buildings And Improvements Intangible Lease Assets And Other LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther	14029059000
CY2021Q4	mpw	Land Buildings And Improvements Intangible Lease Assets And Other LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther	14062722000
CY2022Q1	us-gaap	Net Investment In Lease NetInvestmentInLease	2063227000
CY2021Q4	us-gaap	Net Investment In Lease NetInvestmentInLease	2053327000
CY2021Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	1096505000
CY2022Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	224281000
CY2021Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	213211000
CY2022Q1	mpw	Gross Investment In Real Estate Assets GrossInvestmentInRealEstateAssets	16316567000
CY2021Q4	mpw	Gross Investment In Real Estate Assets GrossInvestmentInRealEstateAssets	17425765000
CY2022Q1	mpw	Real Estate Accumulated Depreciation And Amortization RealEstateAccumulatedDepreciationAndAmortization	1054361000
CY2021Q4	mpw	Real Estate Accumulated Depreciation And Amortization RealEstateAccumulatedDepreciationAndAmortization	993100000
CY2022Q1	mpw	Net Investment In Real Estate Assets NetInvestmentInRealEstateAssets	15262206000
CY2021Q4	mpw	Net Investment In Real Estate Assets NetInvestmentInRealEstateAssets	16432665000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	248846000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	459227000
CY2022Q1	mpw	Interest And Rent Receivable InterestAndRentReceivable	65933000
CY2021Q4	mpw	Interest And Rent Receivable InterestAndRentReceivable	56229000
CY2022Q1	mpw	Straight Line Rent Receivable StraightLineRentReceivable	660421000
CY2021Q4	mpw	Straight Line Rent Receivable StraightLineRentReceivable	728522000
CY2022Q1	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	1534514000
CY2021Q4	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	1152927000
CY2022Q1	mpw	Investments In Unconsolidated Operating Entities InvestmentsInUnconsolidatedOperatingEntities	1455842000
CY2021Q4	mpw	Investments In Unconsolidated Operating Entities InvestmentsInUnconsolidatedOperatingEntities	1289434000
CY2022Q1	mpw	Acquisition Loans And Other Loans AcquisitionLoansAndOtherLoans	66963000
CY2021Q4	mpw	Acquisition Loans And Other Loans AcquisitionLoansAndOtherLoans	67317000
CY2022Q1	us-gaap	Other Assets OtherAssets	523109000
CY2021Q4	us-gaap	Other Assets OtherAssets	333480000
CY2022Q1	us-gaap	Assets Assets	19817834000
CY2021Q4	us-gaap	Assets Assets	20519801000
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	10117989000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	11282770000
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	595026000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	607792000
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	18834000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	25563000
CY2022Q1	mpw	Obligations To Tenants And Other Lease Liabilities ObligationsToTenantsAndOtherLeaseLiabilities	166626000
CY2021Q4	mpw	Obligations To Tenants And Other Lease Liabilities ObligationsToTenantsAndOtherLeaseLiabilities	158005000
CY2022Q1	us-gaap	Liabilities Liabilities	10898475000
CY2021Q4	us-gaap	Liabilities Liabilities	12074130000
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	598676000
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	598676000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	596748000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	596748000
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	599000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	597000
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8547892000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8564009000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	369972000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-87691000
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5010000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-36727000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	8913453000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8440188000
CY2022Q1	us-gaap	Minority Interest MinorityInterest	5906000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	5483000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8919359000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8445671000
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19817834000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20519801000
CY2022Q1	mpw	Rent Billed RentBilled	263402000
CY2021Q1	mpw	Rent Billed RentBilled	213344000
CY2022Q1	mpw	Straight Line Rent Revenue Net Of Write Offs StraightLineRentRevenueNetOfWriteOffs	61044000
CY2021Q1	mpw	Straight Line Rent Revenue Net Of Write Offs StraightLineRentRevenueNetOfWriteOffs	54873000
CY2022Q1	us-gaap	Direct Financing Lease Revenue DirectFinancingLeaseRevenue	51776000
CY2021Q1	us-gaap	Direct Financing Lease Revenue DirectFinancingLeaseRevenue	50894000
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	33578000
CY2021Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	43654000
CY2022Q1	us-gaap	Revenues Revenues	409800000
CY2021Q1	us-gaap	Revenues Revenues	362765000
CY2022Q1	us-gaap	Interest Expense InterestExpense	91183000
CY2021Q1	us-gaap	Interest Expense InterestExpense	86972000
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	85316000
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	75642000
CY2022Q1	mpw	Costs Of Leased And Rented Property Or Equipment CostsOfLeasedAndRentedPropertyOrEquipment	8598000
CY2021Q1	mpw	Costs Of Leased And Rented Property Or Equipment CostsOfLeasedAndRentedPropertyOrEquipment	5453000
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41424000
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36073000
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	226521000
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	204140000
CY2022Q1	mpw	Gain Loss On Sale Of Real Estate And Other Net GainLossOnSaleOfRealEstateAndOtherNet	451638000
CY2021Q1	mpw	Gain Loss On Sale Of Real Estate And Other Net GainLossOnSaleOfRealEstateAndOtherNet	989000
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7338000
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7101000
CY2022Q1	mpw	Debt Refinancing And Unutilized Financing Costs DebtRefinancingAndUnutilizedFinancingCosts	8816000
CY2021Q1	mpw	Debt Refinancing And Unutilized Financing Costs DebtRefinancingAndUnutilizedFinancingCosts	2269000
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9887000
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7794000
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	460047000
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13615000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	643326000
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	172240000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11379000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8360000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	631947000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	163880000
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	266000
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	97000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	631681000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	163783000
CY2022Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	1.05
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.28
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	598676000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	576240000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	598932000
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	577541000
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2022Q1	us-gaap	Profit Loss ProfitLoss	631947000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	163880000
CY2022Q1	mpw	Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax	44932000
CY2021Q1	mpw	Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax	15504000
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-13215000
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-30900000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	663664000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	148484000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	266000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	97000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	663398000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	148387000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8445671000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	631947000
CY2022Q1	mpw	Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax	44932000
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-13215000
CY2022Q1	mpw	Stock Issued During Period Value Stock Vesting And Amortization Of Stock Based Compensation StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation	11804000
CY2022Q1	mpw	Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholding	27919000
CY2022Q1	mpw	Purchase Of Non Controlling Interest PurchaseOfNonControllingInterest	929000
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	772000
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	174018000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8919359000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7343857000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	163880000
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-30900000
CY2021Q1	mpw	Stock Issued During Period Value Stock Vesting And Amortization Of Stock Based Compensation StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation	12264000
CY2021Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	193000
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	779241000
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2021Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	163443000
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8120210000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	631947000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	163880000
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	88760000
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	78606000
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	5285000
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3817000
CY2022Q1	mpw	Straight Line Rent Revenue And Other StraightLineRentRevenueAndOther	75385000
CY2021Q1	mpw	Straight Line Rent Revenue And Other StraightLineRentRevenueAndOther	65333000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11804000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12264000
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	451638000
CY2021Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	989000
CY2022Q1	mpw	Straight Line Rent And Other Recovery Write Off StraightLineRentAndOtherRecoveryWriteOff	2604000
CY2021Q1	mpw	Straight Line Rent And Other Recovery Write Off StraightLineRentAndOtherRecoveryWriteOff	-5238000
CY2022Q1	mpw	Debt Refinancing And Unutilized Financing Costs DebtRefinancingAndUnutilizedFinancingCosts	8816000
CY2021Q1	mpw	Debt Refinancing And Unutilized Financing Costs DebtRefinancingAndUnutilizedFinancingCosts	2269000
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1040000
CY2021Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2923000
CY2022Q1	mpw	Increase Decrease In Interest And Rent Receivable IncreaseDecreaseInInterestAndRentReceivable	12431000
CY2021Q1	mpw	Increase Decrease In Interest And Rent Receivable IncreaseDecreaseInInterestAndRentReceivable	-13396000
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	41000
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	652000
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-21648000
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5062000
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-7646000
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-15429000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	179387000
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	188730000
CY2022Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	724795000
CY2021Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	1778417000
CY2022Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	1711608000
CY2021Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	10905000
CY2022Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	6355000
CY2021Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	40937000
CY2022Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	10414000
CY2021Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	23935000
CY2022Q1	mpw	Construction In Progress Equipment And Other ConstructionInProgressEquipmentAndOther	36115000
CY2021Q1	mpw	Construction In Progress Equipment And Other ConstructionInProgressEquipmentAndOther	9774000
CY2021Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	11000000
CY2022Q1	mpw	Payments For Capital Additions And Other Investments Net PaymentsForCapitalAdditionsAndOtherInvestmentsNet	67605000
CY2021Q1	mpw	Payments For Capital Additions And Other Investments Net PaymentsForCapitalAdditionsAndOtherInvestmentsNet	32276000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	879034000
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1781560000
CY2021Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1839735000
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	869606000
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	689450000
CY2022Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-198599000
CY2021Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	8910000
CY2022Q1	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	176494000
CY2021Q1	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	147666000
CY2022Q1	mpw	Payments For Proceeds From Lease Deposits And Other Obligations To Tenants PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants	-15168000
CY2021Q1	mpw	Payments For Proceeds From Lease Deposits And Other Obligations To Tenants PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants	-12900000
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	779241000
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	27919000
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-6366000
CY2021Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-18479000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1263816000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1785191000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-205395000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	192361000
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4721000
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4356000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	461882000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	556369000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	251766000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	753086000
CY2022Q1	us-gaap	Interest Paid InterestPaid	111012000
CY2021Q1	us-gaap	Interest Paid InterestPaid	82471000
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	174018000
CY2021Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	163443000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	459227000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	549884000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2655000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6485000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	461882000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	556369000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	248846000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	746753000
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2920000
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6333000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	251766000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	753086000
CY2022Q1	mpw	Number Of Facilities NumberOfFacilities	440
CY2022Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	32
CY2022Q1	mpw	Number Of Facilities Sold NumberOfFacilitiesSold	2
CY2022Q1	mpw	Number Of Lessor Properties NumberOfLessorProperties	5
CY2022Q1	us-gaap	Residual Value Of Leased Asset ResidualValueOfLeasedAsset	231000000
CY2022Q1	us-gaap	Direct Financing Lease Lease Receivable DirectFinancingLeaseLeaseReceivable	1172338000
CY2021Q4	us-gaap	Direct Financing Lease Lease Receivable DirectFinancingLeaseLeaseReceivable	1183855000
CY2022Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Certain amounts in the condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation.</span></p>
CY2022Q1	mpw	Loans And Or Equity Investments In Variable Interest Entities LoansAndOrEquityInvestmentsInVariableInterestEntities	600000000
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	25424000
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	724795000
CY2021Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	1778417000
CY2022Q1	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.50
CY2022Q1	mpw	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities And Other Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesAndOtherLiabilities	25400000
CY2022Q1	mpw	Development Projects Original Commitment Amount DevelopmentProjectsOriginalCommitmentAmount	217108000
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	93994000
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	48000000
CY2022Q1	us-gaap	Gain Loss On Disposition Of Real Estate Discontinued Operations GainLossOnDispositionOfRealEstateDiscontinuedOperations	15000000
CY2021Q1	mpw	Number Of Facilities Sold NumberOfFacilitiesSold	1
CY2021Q1	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	11000000
CY2021Q1	us-gaap	Gain Loss On Disposition Of Real Estate Discontinued Operations GainLossOnDispositionOfRealEstateDiscontinuedOperations	1000000.0
CY2022Q1	us-gaap	Lessor Operating Lease Renewal Term LessorOperatingLeaseRenewalTerm	P5Y
CY2022Q1	mpw	Leases Annual Rent Escalations Percentage LeasesAnnualRentEscalationsPercentage	0.99
CY2022Q1	us-gaap	Direct Financing Lease Unguaranteed Residual Asset DirectFinancingLeaseUnguaranteedResidualAsset	203818000
CY2021Q4	us-gaap	Direct Financing Lease Unguaranteed Residual Asset DirectFinancingLeaseUnguaranteedResidualAsset	203818000
CY2022Q1	mpw	Direct Financing Lease Unearned Income And Allowance For Credit Loss DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss	905874000
CY2021Q4	mpw	Direct Financing Lease Unearned Income And Allowance For Credit Loss DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss	918584000
CY2022Q1	us-gaap	Direct Financing Lease Net Investment In Lease DirectFinancingLeaseNetInvestmentInLease	470282000
CY2021Q4	us-gaap	Direct Financing Lease Net Investment In Lease DirectFinancingLeaseNetInvestmentInLease	469089000
CY2022Q1	mpw	Other Financing Leases Net Of Allowance For Credit Loss OtherFinancingLeasesNetOfAllowanceForCreditLoss	1592945000
CY2021Q4	mpw	Other Financing Leases Net Of Allowance For Credit Loss OtherFinancingLeasesNetOfAllowanceForCreditLoss	1584238000
CY2022Q1	us-gaap	Net Investment In Lease NetInvestmentInLease	2063227000
CY2021Q4	us-gaap	Net Investment In Lease NetInvestmentInLease	2053327000
CY2022Q1	mpw	Remaining Outstanding Deferred Rent To Be Received RemainingOutstandingDeferredRentToBeReceived	12400000
CY2022Q1	mpw	Percentage Of Properties Occupied By Tenants PercentageOfPropertiesOccupiedByTenants	0.99
CY2022Q1	mpw	Number Of Properties Vacant NumberOfPropertiesVacant	6
CY2022Q1	mpw	Number Of Vacant Facility Sold NumberOfVacantFacilitySold	1
CY2022Q1	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	1534514000
CY2021Q4	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	1152927000
CY2022Q1	mpw	Investments In Unconsolidated Operating Entities InvestmentsInUnconsolidatedOperatingEntities	1455842000
CY2021Q4	mpw	Investments In Unconsolidated Operating Entities InvestmentsInUnconsolidatedOperatingEntities	1289434000
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	48527000
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8726000
CY2022Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	5412000
CY2022Q1	mpw	Expected Credit Losses Related To Financial Instruments Sold Or Repaid ExpectedCreditLossesRelatedToFinancialInstrumentsSoldOrRepaid	-6000
CY2021Q1	mpw	Expected Credit Losses Related To Financial Instruments Sold Or Repaid ExpectedCreditLossesRelatedToFinancialInstrumentsSoldOrRepaid	-4000
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	53933000
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8722000
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10186149000
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11358826000
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	68160000
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	76056000
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	10117989000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	11282770000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	525520000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1429259000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1473010000
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1910250000
CY2022Q1	mpw	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	4848110000
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10186149000
CY2022Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1000000000
CY2022Q1	us-gaap	Line Of Credit Facility Initiation Date1 LineOfCreditFacilityInitiationDate1	2021-07-27
CY2022Q1	mpw	Percentage Of Dividends Payable On Basis Of Adjusted Operating Funds PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds	0.95
CY2022Q1	mpw	Percentage Of Dividends Payable On Senior Unsecured Notes PercentageOfDividendsPayableOnSeniorUnsecuredNotes	0.95
CY2022Q1	mpw	Maximum Percentage Of Unencumbered Assets MaximumPercentageOfUnencumberedAssets	1.50
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11800000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12300000
CY2022Q1	mpw	Interest And Rent Receivable InterestAndRentReceivable	65933000
CY2022Q1	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	66521000
CY2021Q4	mpw	Interest And Rent Receivable InterestAndRentReceivable	56229000
CY2021Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	56564000
CY2022Q1	mpw	Loans Loans	1110719000
CY2022Q1	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	1115183000
CY2021Q4	mpw	Loans Loans	991609000
CY2021Q4	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	991954000
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	10117989000
CY2022Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	9930403000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	11282770000
CY2021Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	11526388000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	631947000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	163880000
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	266000
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	97000
CY2022Q1	mpw	Undistributed Earning Allocated To Participating Securities UndistributedEarningAllocatedToParticipatingSecurities	402000
CY2021Q1	mpw	Undistributed Earning Allocated To Participating Securities UndistributedEarningAllocatedToParticipatingSecurities	370000
CY2022Q1	mpw	Net Income Less Participating Securities Share In Earnings NetIncomeLessParticipatingSecuritiesShareInEarnings	631279000
CY2021Q1	mpw	Net Income Less Participating Securities Share In Earnings NetIncomeLessParticipatingSecuritiesShareInEarnings	163413000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	598676000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	576240000
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	256000
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1301000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	598932000
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	577541000

Files In Submission

Name	View Source	Status
0000950170-22-009064-index-headers.html	Edgar Link	pending
0000950170-22-009064-index.html	Edgar Link	pending
0000950170-22-009064.txt	Edgar Link	pending
0000950170-22-009064-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mpw-20220331.htm	Edgar Link	pending
mpw-20220331.xsd	Edgar Link	pending
mpw-20220331_cal.xml	Edgar Link	unprocessable
mpw-20220331_def.xml	Edgar Link	unprocessable
mpw-20220331_htm.xml	Edgar Link	completed
mpw-20220331_lab.xml	Edgar Link	unprocessable
mpw-20220331_pre.xml	Edgar Link	unprocessable
mpw-ex31_1.htm	Edgar Link	pending
mpw-ex31_2.htm	Edgar Link	pending
mpw-ex31_3.htm	Edgar Link	pending
mpw-ex31_4.htm	Edgar Link	pending
mpw-ex32_1.htm	Edgar Link	pending
mpw-ex32_2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MPW
MEDICAL PROPERTIES TRUST INC Stock $mpw

2022 Q2 Form 10-Q Financial Statement

#000095017022009064 Filed on May 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPW MEDICAL PROPERTIES TRUST INC Stock $mpw

2022 Q2 Form 10-Q Financial Statement

#000095017022009064 Filed on May 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPW
MEDICAL PROPERTIES TRUST INC Stock $mpw